These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7718037)

  • 21. [Genetic background of human prion diseases].
    Kovács GG
    Ideggyogy Sz; 2007 Nov; 60(11-12):438-46. PubMed ID: 18198790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased prevalence of apolipoprotein E3/E4 genotype among Swedish renal transplant recipients.
    Roussos L; Flor n C; Carlson J; Svensson PJ; Wallmark A; Ekberg H
    Nephron; 1999 Sep; 83(1):25-30. PubMed ID: 10461032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism at 3' UTR +28 of the prion-like protein gene is associated with sporadic Creutzfeldt-Jakob disease.
    Jeong BH; Kim NH; Choi EK; Lee C; Song YH; Kim JI; Carp RI; Kim YS
    Eur J Hum Genet; 2005 Sep; 13(9):1094-7. PubMed ID: 15986038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MHC typing in variant Creutzfeldt-Jakob disease.
    Pepys MB; Bybee A; Booth DR; Bishop MT; Will RG; Little AM; Prokupek B; Madrigal JA
    Lancet; 2003 Feb; 361(9356):487-9. PubMed ID: 12583949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: The apolipoprotein E epsilon4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.
    Inzelberg R; Paleacu D; Chapman J; Korczyn AD
    Clin Neuropharmacol; 2000; 23(4):230-1. PubMed ID: 11020132
    [No Abstract]   [Full Text] [Related]  

  • 26. Apolipoprotein E-epsilon 4 allele doses in late-onset Alzheimer's disease.
    Lucotte G; Turpin JC; Landais P
    Ann Neurol; 1994 Oct; 36(4):681-2. PubMed ID: 7944308
    [No Abstract]   [Full Text] [Related]  

  • 27. Contribution of apolipoprotein E and cathepsin D genotypes to the familial aggregation of Alzheimer's disease.
    Heun R; Ptok U; Kölsch H; Maier W; Jessen F
    Dement Geriatr Cogn Disord; 2004; 18(2):151-8. PubMed ID: 15211070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan.
    Nakayama S; Kuzuhara S
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):643-8. PubMed ID: 10687744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein-epsilon4 and head trauma: Synergistic or additive risks?
    Katzman R; Galasko DR; Saitoh T; Chen X; Pay MM; Booth A; Thomas RG
    Neurology; 1996 Mar; 46(3):889-91. PubMed ID: 8618734
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of bone mineral density with apolipoprotein E phenotype.
    Shiraki M; Shiraki Y; Aoki C; Hosoi T; Inoue S; Kaneki M; Ouchi Y
    J Bone Miner Res; 1997 Sep; 12(9):1438-45. PubMed ID: 9286760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
    Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
    Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The apolipoprotein E-epsilon 4 allele is a risk factor for Alzheimer disease with early and late onset].
    Kurz A; Lautenschlager N; Haupt M; Zimmer R; von Thülen B; Altland K; Lauter H; Müller U
    Nervenarzt; 1994 Nov; 65(11):774-9. PubMed ID: 7816154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between the apolipoprotein E epsilon4 allele (APOE epsilon4) and chronic schizophrenia.
    Town T; Fallin D; Crawford F; Walsh S; Solomon R; Mullan M
    Am J Med Genet; 1997 Jul; 74(4):451-2. PubMed ID: 9259385
    [No Abstract]   [Full Text] [Related]  

  • 34. Apolipoprotein E4: phenotype in patients with Alzheimer's disease.
    Mahieux F; Couderc R; Moulignier A; Bailleul S; Podrabinek N; Laudet J
    Ann Neurol; 1994 Apr; 35(4):506-7. PubMed ID: 8154882
    [No Abstract]   [Full Text] [Related]  

  • 35. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia.
    Geschwind D; Karrim J; Nelson SF; Miller B
    Ann Neurol; 1998 Jul; 44(1):134-8. PubMed ID: 9667603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France).
    Bailleul S; Couderc R; Landais V; Lefèvre G; Raichvarg D; Etienne J
    Hum Hered; 1993; 43(3):159-65. PubMed ID: 8330879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.
    Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
    Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians.
    Davignon J; Bouthillier D; Nestruck AC; Sing CF
    Trans Am Clin Climatol Assoc; 1988; 99():100-10. PubMed ID: 3503432
    [No Abstract]   [Full Text] [Related]  

  • 39. HLA in French patients with variant Creutzfeldt-Jakob disease.
    Laplanche JL; Lepage V; Peoc'h K; Delasnerie-Lauprêtre N; Charron D
    Lancet; 2003 Feb; 361(9356):531-2. PubMed ID: 12583973
    [No Abstract]   [Full Text] [Related]  

  • 40. [Detection of apolipoproteins E5 and E7 by a widely used commercial ApoE IFE kit--evidence provided by genotyping].
    Imura T; Kimura H; Murata S; Yamaguchi T; Kanou A; Nakashima M; Masunaga S; Yanagisawa R; Araki H; Matsuda T; Gejyo F
    Rinsho Byori; 1998 Mar; 46(3):289-93. PubMed ID: 9564770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.